Announced Mon, 12 Jan · 18:52 IST

Compliance -57 (5)

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.1%1-day move

₹2.79

prior close

₹2.79

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0-5.4+0.4+1.1-10.8-9.3-10.4-11.8-12.5-24.4-7.2-6.1-5.7

Up moveDown movePending

AI summary

Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 does not apply to the company for the quarter ended 31st December 2025. The regulation relates to disclosures around interest, dividend, and principal payments on non-convertible securities. The company clarified it has not issued any non-convertible securities, making the regulation inapplicable. Both the certificate of payment and details of unpaid obligations on such securities are marked as 'Not Applicable'.

Likely market impact

This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms that a specific regulation governing non-convertible securities does not apply to the company.